BMJ 379:e071380 Altintas Dogan AD, Hilberg O, Hess S, Jensen TT, Bladbjerg EM, Juhl CB (2022) Respiratory effects of treatment with a Glucagon-Like Peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease
Pathogenesis of type 1 diabetes: established facts and new insights
Treating Learning Disorders: There is potential for Dihexa to be beneficial in treating specific learning disorders, although this application requires more research
Others are investigating whether adding an amylin analogue like cagrilintide to retatrutide could provide additional satiety benefits beyond what the triple agonist achieves alone
The single-dose pen simplifies the injection process, eliminating the need to handle a needle directly
The body adapts during rest, not during the grind